# Ocular Rosacea Biome Study

> **NCT05296837** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 50 (estimated)

## Conditions studied

- Ocular Rosacea
- Antimicrobial Resistance

## Interventions

- **DRUG:** Doxycycline 40 MG ( 20mg twice daily)
- **DRUG:** Doxycycline 200 MG ( 100 mg twice daily)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05296837
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-22
- **Primary completion:** 2025-07-11
- **Final completion:** 2026-07-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05296837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05296837, "Ocular Rosacea Biome Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05296837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*